US Executive Officer Management Changes SEC — October 09, 2026

09-10-2026

On October 7, 2026, BioRestorative Therapies appointed Donald J. Currie as an independent Class I director to fill the vacancy left by Katharyn Field's resignation effective August 31, 2026. Mr. Currie, who has served as CEO and director of Hillcrest Energy Technologies since 2010, joins the Nominating and Corporate Governance and Compensation Committees. The filing discloses a CAD $2,000 monthly cash fee but no equity compensation, and does not report any financial performance metrics for the period.

• · Mr. Currie will not participate in the standard non-employee director compensation program and receives no equity awards disclosed in this filing
• · Board determined Mr. Currie is independent under Nasdaq listing rules and Rule 10A-3 under the Exchange Act
• · Mr. Currie will serve until the 2027 annual meeting of stockholders
• · Company expects to enter into an indemnification agreement with Mr. Currie, referencing Exhibit 10.4 of the September 2, 2026 8-K
• · Mr. Currie has no arrangements with other persons for his appointment and no reportable related-party transactions under Item 404(a)

09-10-2026

Gen Digital Inc. (GENVR) announced that its Board appointed Talbott Roche, CEO and director of Blackhawk Network Holdings since 2016, as an independent director effective October 6, 2026. Her committee assignments have not yet been determined, and she will receive a pro-rated annual cash retainer and full annual equity retainer under the standard non-employee director compensation previously disclosed in the July 28, 2026 proxy statement. The filing contains no quantitative financial results, so no period-over-period performance comparison is possible.

• · Ms. Roche previously served on the board of Electronic Arts Inc. (NASDAQ: EA) from 2016 until August 4, 2026
• · Ms. Roche holds a B.A. in economics from Stanford University
• · Ms. Roche has led Blackhawk through multiple acquisitions and its 2018 take-private transaction
• · Ms. Roche will enter into the Company's standard indemnification agreement covering indemnification to the fullest extent allowed by Delaware law
• · Ms. Roche has no family relationships with directors or executive officers and no material interest in Item 404(a) transactions
• · The press release announcing the appointment is furnished as Exhibit 99.1 under Item 7.01 (Regulation FD) and is not deemed filed under Section 18 of the Exchange Act

09-10-2026

TOP Financial Group Ltd (Nasdaq: TOP) expanded its Board from five to seven directors on October 8, 2026, appointing Dean Huge as an independent director (joining the Audit, Compensation, and Nominating and Corporate Governance Committees) and Yuli Yan as an executive director, who is not independent and has no committee role. The filing discloses an annual US$50,000 fee for Mr. Huge and an annual base salary of US$60,000 for Ms. Yan under an employment agreement as Project Manager of subsidiary TOP AI Inc. No financial performance metrics are reported in this filing.

• · Board expanded from five to seven directors effective October 8, 2026
• · Dean Huge, age 70, previously served as CEO of Innovation Beverage Group (Nasdaq: IBG) through its 2024 IPO and as CFO of Splash Beverage Group (NYSE: SBEV)
• · Yuli Yan, age 40, is Director of Business Operations at HexaGaN, a U.S. semiconductor and AI company, and is not independent
• · Ms. Yan receives no additional compensation for board service and holds no committee seat
• · Board determined Mr. Huge is independent under Nasdaq Listing Rule 5605(a)(2) and Rule 10A-3
• · Mr. Huge's appointment letter may be terminated by either party on two months' written notice
• · Ms. Yan's employment agreement includes one-year post-employment non-compete and non-solicit covenants

09-10-2026

AutoZone, Inc. disclosed that director Claire R. McDonough informed the Board on October 6, 2026 that she will not stand for reelection at the 2026 Annual Meeting of Stockholders. She cited a new executive role at another company whose events calendar conflicts with several future AutoZone board meetings. The filing states her decision was not related to any disagreement with the Company on operations, policies, or practices.

• · Filing date October 9, 2026; event date October 6, 2026 (Item 5.02).
• · The Board stated it would have preferred a different outcome but thanked McDonough for her counsel and insights.
• · Departure is a non-reelection at the 2026 Annual Meeting, not a mid-term resignation.
• · The Company is incorporated in Nevada and trades on the New York Stock Exchange under AZO.

09-10-2026

Victoria's Secret & Co. (NYSE: VSCO) announced that Chief Legal and Compliance Officer Melinda McAfee will leave the company effective March 31, 2027, and the company has begun searching for a successor. Under a Transition and Separation Agreement dated October 7, 2026, McAfee will keep her current role until a successor is appointed, then remain in a non-executive capacity through March 31, 2027, and receive severance under her 2021 Executive Severance Agreement subject to a release of claims and continued compliance with restrictive covenants.

• · Severance is conditioned on a full release of claims and continued compliance with confidentiality, non-solicitation and non-competition covenants
• · McAfee's severance terms reference Section 4 of the Executive Severance Agreement dated June 29, 2021, filed as Exhibit 10.12 to the FY2025 10-K (fiscal year ended January 31, 2026)
• · McAfee's current compensation and benefits remain in effect during the interim period until a successor is appointed

09-10-2026

Avient Corporation (NYSE: AVNT) appointed Mike Frank as President and CEO, effective immediately, succeeding Dr. Ashish K. Khandpur, who stepped down and will serve in an advisory capacity through December 31, 2026. Richard H. Fearon, previously Lead Independent Director, was named Non-Executive Chairman, and the company reaffirmed its full-year and third-quarter 2026 financial guidance issued August 6, 2026. The filing contains no reported financial results, so no period-over-period performance data is disclosed.

• · Khandpur's advisory role runs through December 31, 2026 to facilitate the transition
• · Q3 2026 earnings release is scheduled before market open on November 4, 2026, followed by an 8:00 a.m. ET webcast
• · Board credits Khandpur with a new strategic plan, significant talent recruitment, upgraded R&D, and consistent financial results
• · Mike Frank previously led Monsanto's global Chief Commercial Officer role (2014 to 2017) and holds an MBA from Kellogg

09-10-2026

Pool Corporation disclosed that Senior Vice President Kenneth G. St. Romain's retirement, first announced in a January 12, 2026 8-K, will take effect December 31, 2026. After retiring, Mr. St. Romain will serve in an advisory role to the Chief Executive Officer. The filing describes a planned executive transition with no reported financial impact.

• · Retirement effective date is December 31, 2026
• · Mr. St. Romain will transition to an advisory role reporting to the CEO after retirement
• · Retirement was first disclosed in an 8-K filed January 12, 2026, with the exact date left unspecified until this announcement

09-10-2026

On October 8, 2026, Helder Antunes resigned as a director of Veea Inc. effective immediately, but will continue as Executive Vice President and Chief Revenue Officer; the resignation was stated to be unrelated to any disagreement with management or the Board. Following the resignation, the Board unanimously approved reducing its size from six to five members, and director Alan Black was appointed to the Compensation Committee effective October 8, 2026.

• · Antunes' resignation as director was stated not to result from any disagreement with management or the Board on operations, policies, or practices
• · Antunes retains his executive role as EVP and Chief Revenue Officer
• · Alan Black was appointed to the Compensation Committee of the Board

09-10-2026

Myriad Genetics entered into a Separation Agreement and Release of Claims with Brian Donnelly, its former Chief Commercial Officer, who departed effective September 16, 2026, with his separation occurring September 21, 2026. The agreement, which becomes effective October 14, 2026 absent revocation, provides a lump-sum severance payment of $1,322,294 in exchange for restrictive covenants and a release of claims, plus accelerated vesting of time-based equity awards within two years of the Separation Date. The filing contains no quantitative performance metrics or period-over-period comparisons.

• · Separation Date was September 21, 2026, five days after the stated September 16, 2026 departure effective date
• · Separation Agreement becomes effective October 14, 2026, provided Mr. Donnelly does not revoke it
• · Severance paid under Mr. Donnelly's Severance and Change of Control Agreement
• · Time-based equity awards vesting within two years of the Separation Date accelerate to the Separation Date, with annual installments deemed to vest monthly over that two-year period
• · Performance-based equity awards remain outstanding and vest only if performance conditions are met within two years of the Separation Date

09-10-2026

The Cigna Group disclosed that director Donna F. Zarcone informed the Board on October 6, 2026 that she will retire from the Board effective December 31, 2026. The company states the retirement is not the result of any disagreement with the Company. This is a routine board departure with no disclosed financial impact.

• · Effective date of retirement is December 31, 2026
• · Notice given to the Board on October 6, 2026; 8-K filed October 9, 2026
• · Filing explicitly states no disagreement with the Company as the reason for departure

09-10-2026

Greystone Housing Impact Investors LP (NYSE: GHI) disclosed that director W. Kimball Griffith retired from the Board of Greystone AF Manager LLC, effective October 9, 2026, after serving since 2015 and as a member of the Audit Committee. The Board appointed existing member Robert K. Jacobsen to the Audit Committee as its third independent member, and affirmed his NYSE and SEC independence under the Committee's requirements. The filing states the retirement was not related to any disagreement with the Company or Partnership, and reports no financial figures.

• · Griffith's retirement also constitutes his retirement as the equivalent of a director of the Partnership
• · Griffith was a member of the Audit Committee, and his vacancy was filled by Jacobsen
• · The filing states no disagreement with the Company or Partnership underlies the retirement

09-10-2026

Phoenix Education Partners (PXED) announced that CFO and Treasurer Blair Westblom will separate from the company effective October 10, 2026, with the company stating the departure was not due to any disagreement on financial reporting, internal controls, operations, policies or practices. Michael Cochran, SVP of Corporate Development since April 2026, was appointed interim CFO effective the same date, and Ms. Westblom's separation agreement provides $1,137,204 in aggregate cash severance, her fiscal 2026 cash bonus, and accelerated equity vesting.

• · Westblom's performance stock units remain subject to the applicable performance conditions despite accelerated vesting of other equity awards
• · Westblom's fiscal 2026 cash bonus is based on the percentage authorized by the Compensation Committee
• · No compensation decisions have been made for Cochran's interim CFO role; material changes will be disclosed via 8-K
• · The separation agreement is expected to be filed as an exhibit to the 10-K for fiscal year ending August 31, 2026

09-10-2026

Fluence Energy, Inc. entered into a separation agreement with Peter Williams, its former Senior Vice President and Chief Product Officer, effective October 8, 2026. Under the agreement, Williams receives a lump sum payment of $593,750 (before standard withholdings), accelerated vesting of 12,184 RSUs and 11,347 PSUs, and twelve months of COBRA premium reimbursement, subject to a release of claims. The filing does not disclose any successor appointment or any financial impact on company results.

• · Separation payments and benefits are conditional on Williams executing and not revoking a release of claims, which includes confidentiality, mutual non-disparagement, and cooperation obligations
• · COBRA reimbursement applies only if Williams is eligible and timely elects COBRA coverage
• · Full agreement is filed as Exhibit 10.1 to the 8-K

09-10-2026

BARK, Inc. disclosed that principal accounting officer Brian Dostie resigned, effective October 9, 2026 (with his departure from the company effective October 23, 2026), to pursue another professional opportunity. The resignation was not due to any disagreement with auditors, management, accounting principles, financial statement disclosure, or internal controls. CFO Anya Hamill, in office since September 8, 2026, was designated to also serve as principal accounting officer at no additional compensation.

• · Mr. Dostie's resignation was explicitly not the result of any disagreement with the independent auditors, management, accounting principles, financial statement disclosure, or internal controls
• · Ms. Hamill's compensation and biographical details are incorporated by reference from the company's July 28, 2026 Form 8-K
• · No related-party transactions under Item 404(a) and no family relationships between Ms. Hamill and directors or executive officers
• · Ms. Hamill was not selected under any arrangement or understanding with other persons

09-10-2026

Standard Motor Products announced that CFO Nathan R. Iles will resign to take a CFO position at another public company, effective after remaining in role through October 30, 2026. Former CFO James J. Burke, currently an executive advisor, will serve as Interim CFO from October 30, 2026 while the Company conducts an executive search, and will remain on the Board. The company states the resignation was voluntary and not due to any disagreement, and reports Q3 2026 earnings before market open on October 30, 2026.

• · Burke previously served as CFO from 1999 to 2019, then as COO until June 2026, when he moved to an executive advisor role
• · Iles will remain CFO through October 30, 2026; Burke's interim appointment is effective the same date
• · Company states Iles' resignation was voluntary and not related to any disagreement on operations, financial reporting, policies, or practices
• · Q3 2026 (three and nine months ended September 30, 2026) earnings release scheduled before market open on October 30, 2026; call details to follow

09-10-2026

MSG Sports (MSGS) announced that the spin-off of its New York Rangers business into MSGS Spinco, Inc. is expected to become effective October 26, 2026, with a record date of October 20, 2026. Spinco will trade on the NYSE under the symbol MSGR, while the parent will be renamed MSG Knickerbockers Corp. (MSGK). Stockholders receive one Spinco share for every two MSG Sports shares held, with no action required and no stockholder approval sought; the Dolan family will retain about 63.4% of total voting power.

• · Spinco Class B Common Stock will not be listed on any securities exchange
• · Spinco is a controlled company under NYSE standards and an emerging growth company
• · Distribution is intended to be tax-free for U.S. federal income tax purposes, subject to a Sullivan & Cromwell opinion; cash is paid in lieu of fractional shares
• · Distribution is effective at 11:59 p.m. New York City time on October 26, 2026
• · NHL U.S. national media rights with Disney and WarnerMedia expire after the 2027-28 season; MSG Networks local telecast rights expire after the 2028-29 season
• · The 8-K covers Item 5.02 (officer/director matters), Item 8.01 (other events) and Item 9.01 (financial statements and exhibits) via the information statement exhibit

09-10-2026

Quantum Corporation (QMCO) terminated CFO William H. White effective October 9, 2026, and appointed Chief Accounting Officer Hiral A. Patel as Principal Financial Officer the same day, with the company stating no operational disruption is expected and that it still expects to timely file its 10-Q for the quarter ended September 30, 2026. The company also said it expects to meet or exceed previously issued guidance for that quarter, though it is early in its financial close and the expectation remains subject to completion of closing procedures and auditor review. The filing also disclosed board committee changes following James C. Clancy's resignation from the Audit and Nominating Committees.

• · Patel previously served as Chief Accounting Officer at Pep Boys (Oct 2025 to Jun 2026), Vice President and Controller at IKEA Retail (Mar 2024 to Oct 2025), and Senior Director of Accounting at VeriFone Systems (Sep 2020 to Mar 2024)
• · Patel is a Certified Public Accountant with a Bachelor of Business Administration from Temple University
• · Patel has been Chief Accounting Officer since September 1, 2026
• · James C. Clancy resigned from the Board and its committees on September 28, 2026 upon appointment as Chief Operating Officer; the Board filled his Audit Committee seat with Yue Zhou White and his Nominating Committee seat with Donald J. Jaworski on October 9, 2026
• · Filing states there are no related-party transactions or family relationships involving Patel, and no arrangement under which she was selected as an officer
• · The previously issued 10-K was filed June 25, 2026

09-10-2026

Mitek Systems announced that Michael E. Diamond, Senior Vice President of Sales, Check Verification and a named executive officer for fiscal year 2026, will leave the company, with his employment terminating on December 8, 2026. Diamond will receive separation benefits as a termination without cause under the Company's Executive Severance and Change of Control Plan. The filing does not disclose any financial results or quantitative performance metrics.

• · Termination effective date is December 8, 2026, roughly two months after the October 9, 2026 announcement
• · Termination is without cause, so separation benefits apply under the existing severance plan, which was previously filed with the SEC
• · Diamond was a named executive officer for fiscal year 2026, so the departure concerns a senior executive

09-10-2026

Sidus Space, Inc. (SIDU) disclosed that two directors, Tiffany Norwood and Kelle Wendling, resigned from the Board on October 6, 2026. Ms. Norwood also stepped down as Audit Committee Chairwoman and from the Corporate Governance/Nominating Committee, citing disagreements over governance and oversight, including the handling of a confidential complaint. Ms. Wendling cited concerns about management and governance and also left the Audit, Compensation, and Corporate Governance/Nominating Committees. The Company disputes the substance and characterizations in both resignation letters.

• · Norwood resigned effective October 6, 2026 at 7:15 p.m. ET; Wendling resigned effective October 6, 2026 at 1:00 p.m. ET
• · Norwood's resignation letter is filed as Exhibit 17.1 and Wendling's as Exhibit 17.2
• · Norwood cited disagreements over governance and oversight, including handling of a confidential complaint
• · Both directors were given the opportunity to submit letters stating whether they agree with the Company's disclosure; any such letter will be filed by amendment within two business days of receipt
• · The Audit Committee chair position is now vacant, and the Audit and Compensation Committee compositions have changed, which may require governance follow-up

09-10-2026

NextBoat Inc. (NYSE American: NXB), filing under the ticker OTH in the request, disclosed that Chief Financial Officer Chad Corbin notified CEO Ross Tannenbaum on October 5, 2026 of his decision to resign. Corbin will remain in the CFO role during a transition period until a successor is identified, and the company states the departure was not due to any disagreement on operations, policies, or practices.

• · Resignation notice dated October 5, 2026; 8-K filed October 9, 2026 under Item 5.02
• · Corbin remains CFO during an unspecified transition period until a successor is named
• · Company describes the departure as on good terms, with no disagreement cited
• · Common stock (par value $0.001) trades as NXB on NYSE American; company is an emerging growth company
• · Filing does not name a successor CFO or disclose any compensation arrangements

09-10-2026

HealthEquity, Inc. (HQY) disclosed that Chief Commercial Officer Michael Fiore's employment was terminated without cause effective October 5, 2026, with his responsibilities being redistributed across the existing management team. Mr. Fiore's severance and equity treatment are tied to a release of claims and continuing restrictive covenant compliance, with terms previously disclosed in the May 13, 2026 proxy statement and governed by the 2014 and 2024 Stock Incentive Plans.

• · Termination was without cause, meaning the departure was initiated by the company rather than for misconduct
• · No specific severance dollar amounts are disclosed in this filing; they are referenced to the May 13, 2026 proxy statement
• · Severance payments are conditioned on a release of claims and continuing compliance with restrictive covenants
• · Filing was signed by CFO James Lucania on October 9, 2026

09-10-2026

Moleculin Biotech, Inc. held its 2026 Annual Meeting of Stockholders on October 9, 2026, where shareholders elected all five director nominees, ratified Grant Thornton LLP as auditor, and approved a 3,861,894-share increase to the 2024 Stock Plan (bringing the total authorized to 3,875,999 shares). Stockholders also approved a board-authorized reverse stock split (1-for-2 to 1-for-20) and adjournment authority, but the proposal to eliminate supermajority voting requirements failed, and the advisory say-on-pay vote received notably more opposition than support in its vote count.

• · Supermajority voting elimination charter amendment failed to reach the two-thirds outstanding-share threshold, leaving the existing requirement in place
• · Advisory say-on-pay vote had roughly 2.9M for versus 0.9M against, a comparatively weak shareholder endorsement of executive pay
• · Board received authority for a reverse split between 1-for-2 and 1-for-20, exercisable before the one-year anniversary of the meeting, which may signal share price or Nasdaq listing considerations
• · Director votes withheld ranged from roughly 756,977 to 841,135, with the Klemp nomination receiving the most withheld votes
• · Filing is a Form 8-K under Items 5.02, 5.07 and 9.01; the amended 2024 Plan is filed as Exhibit 10.1

09-10-2026

Vistagen Therapeutics' Board approved on October 7, 2026 an amended and restated Change in Control Executive Severance Plan (effective the same day), which extends severance benefits to Eligible Employees for involuntary terminations without Cause even outside a Change in Control. The plan requires at least 12 months of full-time employment to qualify, and all current executive officers are Eligible Employees. The filing discloses no departure, appointment, or dollar amount of severance payments.

• · The original plan was adopted effective August 11, 2026 and disclosed in the Q2 2026 Form 10-Q.
• · Severance under the non-Change-in-Control provision is a lump sum of monthly base salary times the severance period, plus a lump sum of monthly COBRA premium times the benefits continuation period, subject to a release of claims.
• · The Change in Control definition is now set out directly in the Plan rather than by reference.

09-10-2026

AgEagle Aerial Systems Inc. (UAVS) disclosed that Chief Operating Officer Brent Pope notified the company on October 5, 2026 of his intention to retire, effective November 30, 2026. The company states the retirement was not the result of any disagreement regarding its operations, policies, or practices, and that Mr. Pope will assist with the transition of his responsibilities until his retirement date. The company will commence a search for a successor.

• · Retirement effective date is November 30, 2026
• · Retirement is explicitly stated not to stem from any disagreement with the company
• · Company has not yet named a successor and will begin a search

09-10-2026

Quince Therapeutics (Nasdaq: QNCX) announced it is renaming itself IRulya Therapeutics Inc., with common stock to trade under the ticker 'IRLA' on the Nasdaq Capital Market effective October 12, 2026, following its merger with Orphai Therapeutics and a roughly $115 million concurrent private placement in May 2026. The company appointed Brigette Roberts, M.D. as CEO, John Militello, CPA as CFO, and Keith R. Fandrick, Ph.D. as COO, and added five new directors, while former CEO/CMO Dirk Thye and COO/CBO/CCO Brendan Hannah resigned. Cash of $116 million as of June 30, 2026 is expected to fund operations through the end of 2028, but the company is still pre-revenue with all three LAM-001 Phase 2 readouts pending.

• · Dirk Thye resigned as CEO, CMO and board member; Brendan Hannah resigned as COO, CBO and CCO, indicating a substantial leadership turnover
• · Series C preferred stock converts automatically into common stock at 5:00 p.m. ET on October 9, 2026, following stockholder approval on October 6, 2026
• · Phase 2 BOS data expected 1Q27; Phase 2b PH-ILD data expected 1Q28; Phase 2 SAPH data expected 4Q28
• · Brigette Roberts also continues to serve on the Board while acting as CEO
• · Quince's prior 10-Q filing (August 14, 2026) is referenced for risk factors, and the release carries standard forward-looking statement cautions regarding clinical, regulatory and funding risks

09-10-2026

Zedge, Inc. (NYSE American: ZDGE) disclosed that Morris Berger began service as Chief Executive Officer effective October 1, 2026, under a three-year employment agreement signed September 29, 2026. Compensation includes a $450,000 annual base salary, a $25,000 signing bonus, a $25,000 stay bonus after the first anniversary, one year of base salary as severance, and a 10-year option award for 3% of outstanding shares vesting over five years, with no vesting before stockholder approval of a Plan amendment.

• · Options vest only after stockholder ratification of a Plan amendment adding the underlying shares; options that would have vested earlier vest on the first scheduled date after approval
• · Severance equals one year of base salary; full option acceleration on termination without Cause or resignation for Good Reason
• · Employee works remotely and must devote 100% of business time to the Company
• · Option exercise price equals fair market value on grant date; grant expected within 30 days of Start Date
• · Previously announced appointment in an August 31, 2026 Form 8-K

09-10-2026

Enerpac Tool Group (NYSE: EPAC) announced on October 8, 2026 that its Board of Directors expanded the Board from eight to nine members and elected Charles T. Lauber as a director effective immediately. Mr. Lauber is a retired finance executive who served as EVP and Chief Financial Officer of A. O. Smith from 2019 to 2026 after a 27-year career there. The announcement is a board governance change and does not disclose any financial results, deal terms, or operating metrics.

• · Mr. Lauber currently sits on the H.B. Fuller Company (NYSE: FUL) Board, serving on its Audit Committee and Personnel & Compensation Committee
• · Mr. Lauber holds a bachelor's degree in accounting from University of Wisconsin-Whitewater and an MBA from Kellogg School of Management at Northwestern University
• · Mr. Lauber retired from A. O. Smith earlier in 2026, before this board appointment
• · Board expansion and appointment are effective immediately; the filing does not indicate committee assignments for Enerpac

09-10-2026

HubSpot, Inc. disclosed that Chief Legal Officer and Corporate Secretary Erika Fisher notified the company on October 8, 2026 of her resignation, effective November 6, 2026, to pursue another professional opportunity. The company states the departure was not due to any disagreement on operations, policies, or practices, and Ms. Fisher will remain in her role through the effective date to support an orderly transition. HubSpot has begun a search for a successor Chief Legal Officer.

• · Resignation notice dated October 8, 2026; effective date November 6, 2026
• · Resignation explicitly stated as not resulting from any disagreement with the company
• · Ms. Fisher remains in role through effective date to ensure orderly transition of responsibilities

09-10-2026

Jazz Pharmaceuticals disclosed that Samantha Pearce, Executive Vice President and Chief Commercial Officer, has notified the Company of her intent to retire from that role, effective upon the earlier of the appointment of a successor or June 30, 2027. The Company plans to launch a formal search for her successor, considering both internal and external candidates. The filing contains no financial results or quantitative performance data.

• · Retirement timing is the earlier of successor appointment or June 30, 2027
• · Successor search will consider both internal and external candidates

09-10-2026

The Marzetti Company (MZTI) disclosed that Tanya Berman, President of the Retail Division of subsidiary T. Marzetti Company, will no longer serve in that role effective October 6, 2026, and will remain an employee until December 31, 2026. The Company expects to enter into a severance agreement with Ms. Berman, but its terms have not yet been determined and will be disclosed in a future SEC filing once executed.

• · Ms. Berman's role ends October 6, 2026, with employment continuing through December 31, 2026
• · Severance agreement terms are undetermined and will be disclosed in a future filing once executed

09-10-2026

Goldenwell Biotech, Inc. (GWLL) appointed Ming Zhou, age 57, as a director on October 8, 2026, expanding the board to four members. In connection with her appointment, CEO and director Shuang Liu gifted 20,000,000 shares of common stock (approximately 20.2% of outstanding shares) to Ms. Zhou. The filing discloses no financial results, and no mention of any negative or flat performance metrics.

• · Ms. Zhou has served as Managing Director of Get Health Co., Ltd. and Get Intertrading Co., Ltd. in Samutprakan, Thailand since 2021, with involvement in health products, nutritional supplements, herbal products, cosmetics, distribution, trading, warehousing, and direct-sales businesses
• · Ms. Zhou received an Associate's Degree in Business Administration from China Central Radio and TV University (1991-1993)
• · The filing states no family relationships exist between Ms. Zhou and any director or executive officer, and no related-party transactions under Item 404(a) since the start of the last fiscal year

09-10-2026

Vogenx, Inc. (Nasdaq: VOGX) announced that Board member Richard Gorman, an independent director since 2022, will join the management team as Chief Commercial Officer effective October 12, 2026, and will resign from the Board and its committees at that time. The newly created role covers commercial operations, corporate strategy, and initially business development and partnering/licensing for mizagliflozin, which is in clinical development for post-bariatric hypoglycemia (PBH), gastroparesis, and GIP-dependent Cushing's Syndrome. The Company will search for a new independent director. The filing contains no quantitative financial results; the only figures relate to Mr. Gorman's career history.

• · Mr. Gorman's appointment is effective October 12, 2026, and he resigns from the Board and all committees concurrently
• · Vogenx will conduct a search for a new independent director, so Board seat is vacant pending replacement
• · Mr. Gorman's role is newly created and initially includes business development and partnering/licensing responsibilities
• · Company cites reliance on a small number of key personnel and dependence on its license from Kissei Pharmaceutical as risk factors
• · Vogenx completed its IPO in August 2026 (prospectus filed under Rule 424(b)(4) on August 12, 2026)

09-10-2026

Cisco Systems, Inc. (CSCO) appointed Girish D. Rishi, CEO of Cognite Holding B.V., to its Board of Directors effective October 9, 2026, with the Board determining him to be independent under Nasdaq listing standards. Committee assignments have not yet been determined. This is a board governance update with no reported financial performance metrics, so there is no period-over-period performance to compare.

• · Mr. Rishi's board appointment is effective October 9, 2026; the Board appointed him on October 7, 2026
• · Mr. Rishi entered into Cisco's standard form Indemnity Agreement, filed previously as Exhibit 10.1 to a January 25, 2021 Form 8-K
• · Committee assignments for Mr. Rishi have not yet been determined